Healthcare Informatics Research10.4258/hir.2022.28.2.1122022282112-122Applying the OMOP Common Data Model to Facilitate Benefit-Risk Assessments of Medicinal Products Using Real-World Data from Singapore and South KoreaHui Xing Tan, Desmond Chun Hwee Teo, Dongyun Lee, Chungsoo Kim, Jing Wei Neo, Cynthia Sung, Haroun Chahed, Pei San Ang, Doreen Su Yin Tan, Rae Woong Park, Sreemanee Raaj Dorajoo,,
Drug Safety10.1007/s40264-014-0221-420143711893-896Converting to a Common Data Model: What is Lost in Translation?Peter R. Rijnbeek,,
BMC Medical Informatics and Decision Making10.1186/s12911-021-01520-y2021211An OMOP-CDM based pharmacovigilance data-processing pipeline (PDP) providing active surveillance for ADR signal detection from real-world data sourcesHyunah Shin, Suehyun Lee,,
Real-World Data & Evidence10.37489/2782-3784-myrwd-420211116-20Applying real-world data to justify requirements to purchased drugs in public procurementM. A. Borzova,
BMC Medical Research Methodology10.1186/s12874-021-01434-32021211Standardizing registry data to the OMOP Common Data Model: experience from three pulmonary hypertension databasesPatricia Biedermann, Rose Ong, Alexander Davydov, Alexandra Orlova, Philip Solovyev, Hong Sun, Graham Wetherill, Monika Brand, Eva-Maria Didden,,
JAMIA Open10.1093/jamiaopen/ooac021202251Trajectories: a framework for detecting temporal clinical event sequences from health data standardized to the Observational Medical Outcomes Partnership (OMOP) Common Data ModelKadri Künnapuu, Solomon Ioannou, Kadri Ligi, Raivo Kolde, Sven Laur, Jaak Vilo, Peter R Rijnbeek, Sulev Reisberg,
Journal of Medical Systems10.1007/s10916-019-1436-920194310Feasibility of Mapping Austrian Health Claims Data to the OMOP Common Data ModelAndrea Haberson, Christoph Rinner, Alexander Schöberl, Walter Gall,,
Real-World Data & Evidence10.37489/2782-3784-myrwd-920222128-35Aspects of the safe use of medicinal products based on medicinal plant materials in COVID-19A. A. Taube
eGEMs (Generating Evidence & Methods to improve patient outcomes)10.13063/2327-9214.111020142115Transforming the Premier Perspective® hospital database to the OMOP Common Data ModelRupa Makadia, Patrick B. Ryan
Pharmacoepidemiology and Drug Safety10.1002/pds.47522019284443-451Personalized benefit‐risk assessments combining clinical trial and real‐world data provide further insights into which patients may benefit most from therapy: Demonstration for a new oral antiplatelet therapyCathy Anne Pinto, Tommi Tervonen, Kevin Marsh, Dimitra Lambrelli, Anna Schultze, Andrew Tershakovec, Johanna Hyacinthe, Thibaud Prawitz, Tarek A. Hammad,,,